loader2
Partner With Us NRI

Sanjivani Paranteral Ltd share Price Today

Company details

147.15
157.70
31.67
188.35
6M Return 38.89%
1Y Return 393.42%
Mkt Cap.(Cr) 175.26
Volume 8,929
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 8,929

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Sanjivani Paranteral Ltd shares SWOT Analysis

Strengths (4)

  • Company with high TTM EPS Growth
  • Increasing Revenue every quarter for the past 3 quarters
  • Book Value per share Improving for last 2 years

Weakness (3)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (1)

  • Highest Recovery from 52 Week Low

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 156.1
R2 162.2
R3 166.7
Pivot

151.63

S1 145.6
S2 141.1
S3 135.0
EMA SMA
148.0
154.6
148.7
127.9
149.6
160.3
155.6
123.0
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
SUREKHA HARAN Bulk Sell 2023-12-20 152.7 101034 BSE
SUREKHA HARAN Bulk Purchase 2023-09-18 100.05 50000 BSE
SETU SECURITIES PVT. LTD. Bulk Purchase 2023-09-15 100.06 50000 BSE
Name Category Shares
Ashwani Khemka PROMOTER 25.9%
Naina Khemka PROMOTER 1.78%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Sanjivani Paranteral Ltd Stocks COMPARISON

Financials( in Cr) Sanjivani Paranteral Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Zydus Lifesciences Ltd
Price 150.00 1,620.55 1,496.95 6,157.90 1,007.35
% Change -1.57 1.02 2.30 1.88 0.77
Mcap Cr 175.26 388,824.23 120,856.26 102,719.31 101,964.37
Revenue TTM Cr 41.47 43,885.68 15,790.60 24,669.70 17,237.40
Net Profit TTM Cr 4.51 8,560.84 2,513.47 4,507.30 1,997.30
PE TTM 29.71 41.45 30.52 19.64 30.51
1 Year Return 393.42 64.78 68.33 37.28 109.04
ROCE 7.94 16.79 14.76 25.99 16.25
ROE 12.85 16.46 10.66 21.21 14.05
INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: -3.07 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 29,068.81 33,709.58
LAST 3M 68,518.10 30,558.15
LAST 6M 130,081.93 64,349.19
LAST 12M 189,941.35 208,211.24

Sanjivani Paranteral Ltd Information

Stock PE (TTM)
29.71
Promoter Holding
27.67%
Book Value
19.6527
ROCE
7.94%
ROE
12.85%
Description
  • Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a public limited company in Oct.`94, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company has been involved in the manufacturing of pharmaceutical medicines. The Company`s products includes oral solids, small volume parenteral and sterile powder formulations. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.`96 to part-finance the project. The promoters have received firm inquiries from reputed pharmaceutical companies like Merind, Lupin Laboratories and USV for the first year` production of liquid vials and ampules. During the year 1998-99, the Company has been approved by the WHO GMP Certificate. The Company is hoping for export of its products in Africa, Europe & Latin America. The Company has also tied up with Cadila Ltd., Alkem Ltd., Indian Immunologicals Ltd for marketing its products. During the year 1999-2000, the company has tied-up with India`s first ranked pharmaceutical giant Ranbaxy for manufacturing its products. During 2009, the Company acquired a new pharmaceutical manufacturing plant in Uttarakhand.

Registered Address

205 P N Khotari Indl Estate, LBS Marg Bhandup (West), Mumbai, Maharashtra, 400078

Tel : 91-22-67290900
Email : corporate:sanjivani.co.in; info:sanjivani.co.in, s
Website : http://www.sanjivani.co.in
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 531569
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : XT
ISIN : INE860D01013

FAQ’s on Sanjivani Paranteral Ltd Shares

You can buy Sanjivani Paranteral Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Sanjivani Paranteral Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Mar 28, 2024 04:01 PM the closing price of Sanjivani Paranteral Ltd was ₹ 150.00.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Mar 28, 2024 04:01 PM, the market cap of Sanjivani Paranteral Ltd stood at ₹ 175.26.

The latest PE ratio of Sanjivani Paranteral Ltd as of Mar 28, 2024 04:01 PM is 29.71

The latest PB ratio of Sanjivani Paranteral Ltd as of Mar 28, 2024 04:01 PM is 0.13

The 52-week high of Sanjivani Paranteral Ltd share price is ₹ 188.35 while the 52-week low is ₹ 31.67

Download Our

Download App
market app